As expected, variants associated with an increase in ALT and AST tend to be associated with a proportional increase in liver disease risk (across all lead variants, Pearson correlation of betas r = 0.82 for both enzymes; Fig. 3). The gene discussed is GPT; the disease is liver disorder.